Webinar Series: Immunology without Borders

The IUIS Webinar Series was established at the beginning of 2020 as an online education programme with the aim to provide individuals from all around the world the opportunity to gain comprehensive knowledge on the latest COVID-19 research developments without the need of travelling in these uncertain times. This first series was a tremendous success:
internationally-acclaimed speakers shared their insights and latest research results on COVID-19-related topics in 20 webinars that welcomed more than 8,800 scientists from 86 countries.
For its second series, IUIS, in partnership with Immunopaedia, will broaden the scope to cover a variety of hot topics in
immunological research such as Autoimmunity, Infectious Diseases and Allergology.

Upcoming Webinars

Harnessing innate immunity in cancer therapy and beyond

Date: March 1, 2021
Time: 3 PM CET

New therapies that promote antitumor immunity have been recently developed. Most of these immunomodulatory approaches have focused on enhancing T-cell responses. Although these therapies have led to unprecedented successes, only a minority of cancer patients benefit from them, highlighting the need to identify new cells and molecules that could be exploited in the next generation of immunotherapy. Given the crucial role of innate immune responses in immunity, harnessing these responses opens up new possibilities for long-lasting, multilayered tumor control. We will present innovative anti-tumor therapies based on the manipulation of the innate immune system. In addition, given the urgent need for effective treatments for pneumonia in patients with COVID-19, the elucidation of the immune responses that occur during the course of COVID-19 could lead to the repurposing of approved immunomodulatory drugs and candidate drugs that have already been tested in clinical trials. Along this line, we will present our results indicating the association of COVID-19 inflammation with activation of the C5a–C5aR1 axis. 

Speaker: Eric Vivier

Éric Vivier, DVM, PhD completed his post-doctoral training at Harvard Medical School, then joined Aix-Marseille University as professor at the Centre d’Immunologie de Marseille-Luminy (CIML) in 1993 before becoming its director from 2008 to 2017. He is Professor of Immunology at Aix-Marseille University and at the Public Hospital of Marseille (AP-HM) in addition to being Scientific Director of Innate Pharma, a biotechnology company dedicated to improving cancer treatment with innovative therapeutic antibodies that exploit the immune system. Eric Vivier’s work focuses on innate immunity and in particular Natural killer and other innate lymphoid cells, at Ciml, at AP-HM and at Innate-Pharma.

Moderator: Miriam Merad

Miriam Merad, M.D.; Ph.D. is the Mount Sinai Endowed professor in Cancer Immunology and the Director of the Precision Immunology Institute at Mount Sinai School of Medicine in New York. Dr. Merad also co-leads, the Cancer Immunology program at The Mount Sinai Tisch Cancer Institute and is the Director of the Mount Sinai Human Immune Monitoring Center (HIMC).

Miriam Merad is the Vice-President of IUIS.

On demand Webinars

Please find below the on demand Webinars from the IUIS Webinar Series “Immunology without Borders”. This Series was started in February of 2021 and includes a wide arrays of topics.

Pamela Ohashi: Immunoregulation and the tumor microenvironment

Although PD-1 blockade has transformed cancer treatment, a deeper understanding of tumor immunobiology and inhibitory mechanisms are needed to take immunotherapy to the next level. This webinar will cover topics including the cell types that express key B7 family members and their receptors including PD-L1, B7-H3, B7-H4 and PD-1 and discuss whether these findings align with the traditional views for what is going on in the tumor microenvironment. In addition, it will cover unexpected immunoregulatory mechanisms that we have found focussing on innate lymphoid cells. 

This webinar is supported by: Thermo Fisher Scientific

The production of this webinar is supported by Thermo Fisher Scientific. Thermo Fisher Scientific has had no influence on the content, and full editorial control remains the sole responsibility of IUIS.

Thermo Fisher Scientific understands your samples are precious in immunology research. Our products and technologies support your wise use of samples to get qualitative and quantitative measurements when evaluating experiments. Our mission is to enable our customers to make the world healthier, cleaner, and safer.